Are stem cell marker expression and cd133 analysis relevant to differentiate colorectal cancer?
ABCD (São Paulo, Impr.); 33 (4), 2020
ABSTRACT Background: CD133 and AXL have been described as cancer stem cell markers, and c-MYC as a key regulatory cellular mechanism in colorectal cancer (CRC). Aim: Evaluate the prognostic role of the biomarkers CD133, AXL and c-MYC and their association with clinicopathologic characteristics in colo...